Assessing depression improvement with the remission evaluation and mood inventory tool (REMIT)

Gen Hosp Psychiatry. 2019 Sep-Oct:60:44-49. doi: 10.1016/j.genhosppsych.2019.07.007. Epub 2019 Jul 12.

Abstract

Objective: The Remission Evaluation and Mood Inventory Tool (REMIT) was developed as a brief complementary measure to provide a more robust assessment of depression improvement than tracking DSM-V symptom improvement alone. This study provides further validation of the REMIT tool and examines its utility in predicting depression improvement.

Methods: The sample comprised 294 primary care patients enrolled in a telecare trial of pain plus depression and/or anxiety. Assessments collected included: REMIT, PHQ-9 and measures assessing anxiety, pain, sleep, fatigue, somatization, health-related quality of life and disability. Data was analyzed to assess the REMIT's validity, its minimally important difference (MID), and its utility in predicting 6-month depression improvement.

Results: Convergent and construct validity of REMIT was supported by moderate correlations with mental health measures and weaker correlation with physical health measures. MID of approximately 2 points for REMIT was estimated by two metrics: 0.5 standard deviation and 1 standard error of measurement. Both baseline and 3-month change in REMIT scores predicted depression improvement at 6 months. Indeed, REMIT was as good or better predictor than the PHQ-9.

Conclusion: The REMIT measure is a brief 5-item tool that augments core DSM-V symptom-oriented metrics in assessing and predicting recovery from major depression.

Keywords: Depression; Measurement-based care; Recovery; Remission; Remission evaluation and mood inventory tool (REMIT).

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Validation Study

MeSH terms

  • Adult
  • Affect*
  • Aged
  • Aged, 80 and over
  • Depressive Disorder, Major / rehabilitation
  • Depressive Disorder, Major / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care / standards*
  • Psychiatric Status Rating Scales / standards*
  • Randomized Controlled Trials as Topic
  • Remission Induction